83 related articles for article (PubMed ID: 3839684)
21. Surfactant dysfunction in diabetic offspring: inhibitors and fatty acid lecithin content.
Sosenko IR; Werthammer J; Cunningham MD; Frantz ID
J Appl Physiol Respir Environ Exerc Physiol; 1983 Apr; 54(4):1097-100. PubMed ID: 6687881
[TBL] [Abstract][Full Text] [Related]
22. Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice.
Bernhard W; Wang JY; Tschernig T; Tümmler B; Hedrich HJ; von der Hardt H
Thorax; 1997 Aug; 52(8):723-30. PubMed ID: 9337833
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the alkyl ether species of phosphatidylcholine in bovine heart.
Pugh EL; Kates M; Hanahan DJ
J Lipid Res; 1977 Nov; 18(6):710-6. PubMed ID: 562912
[TBL] [Abstract][Full Text] [Related]
24. [Changes in the surface-active substance in the lungs of rabbits during endotracheal fluothane anesthesia].
Umarkhodzhaev EM; Agabekova II; Linchevskaia AA
Biull Eksp Biol Med; 1977 Oct; 84(10):423-5. PubMed ID: 578779
[TBL] [Abstract][Full Text] [Related]
25. Structural identification of platelet activating factor in psoriatic scale.
Mallet AI; Cunningham FM
Biochem Biophys Res Commun; 1985 Jan; 126(1):192-8. PubMed ID: 3970690
[TBL] [Abstract][Full Text] [Related]
26. Ether-linked lipids of Balb/c3T3, SV3T3 and concanavalin A-selected SV3T3 revertant cells.
Fallani A; Bracco M; Tombaccini D; Mugnai G; Ruggieri S
Biochim Biophys Acta; 1982 May; 711(2):208-12. PubMed ID: 6284240
[TBL] [Abstract][Full Text] [Related]
27. Ether lipids in the cell membrane of Mycoplasma fermentans.
Wagner F; Rottem S; Held HD; Uhlig S; Zähringer U
Eur J Biochem; 2000 Oct; 267(20):6276-86. PubMed ID: 11012682
[TBL] [Abstract][Full Text] [Related]
28. Phosphatidylethanolamine of lung surfactant: proportion and fatty acid patterns of the alkylacyl, alkenylacyl and diacyl subclasses.
Rüstow B; Goracci G; Porcellati S; Anceschi MM; Kunze D
Biochim Biophys Acta; 1988 Aug; 961(3):371-3. PubMed ID: 3401501
[TBL] [Abstract][Full Text] [Related]
29. Functional and biochemical characterization of immunologically derived equine platelet-activating factor.
Wimberly HC; Slauson DO; Neilsen NR
Vet Pathol; 1985 Jul; 22(4):375-86. PubMed ID: 4035942
[TBL] [Abstract][Full Text] [Related]
30. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.
Triggiani M; Connell TR; Chilton FH
J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931
[TBL] [Abstract][Full Text] [Related]
31. A novel approach to structure proof of glyceryl ether-containing glycerophospholipids. Base-catalyzed methanolysis of platelet-activating factor (AGEPC) at 60 degrees C.
Hanahan DJ; Weintraub ST; Friedberg SJ; Tokumura A; Ayer DE
J Lipid Res; 1985 Nov; 26(11):1345-55. PubMed ID: 4067422
[TBL] [Abstract][Full Text] [Related]
32. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.
Postle AD; Mander A; Reid KB; Wang JY; Wright SM; Moustaki M; Warner JO
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):90-8. PubMed ID: 9870921
[TBL] [Abstract][Full Text] [Related]
33. Quantitative determination of alk-1-enyl- and alkyl-glyceryl ethers in neutral lipids and phospholipids.
Wood R; Snyder F
Lipids; 1968 Mar; 3(2):129-35. PubMed ID: 17805900
[TBL] [Abstract][Full Text] [Related]
34. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia.
Schmidt R; Meier U; Yabut-Perez M; Walmrath D; Grimminger F; Seeger W; Günther A
Am J Respir Crit Care Med; 2001 Jan; 163(1):95-100. PubMed ID: 11208632
[TBL] [Abstract][Full Text] [Related]
35. Molecular species of phosphatidylcholine from rat gastric mucosa.
Wassef MK; Lin YN; Horowitz MI
Biochim Biophys Acta; 1979 Apr; 573(1):222-6. PubMed ID: 582288
[TBL] [Abstract][Full Text] [Related]
36. Isolation of a phospholipid inhibitor of platelet activating factor-induced activity from perfused rat liver: identification as phosphatidylglycerol.
Lekka M; Tokumura A; Tsuji H; Hanahan DJ
Arch Biochem Biophys; 1993 May; 302(2):380-4. PubMed ID: 8489242
[TBL] [Abstract][Full Text] [Related]
37. The effect of phospholipase C on human blood platelets.
Otnaess AB; Holm T
J Clin Invest; 1976 Jun; 57(6):1419-25. PubMed ID: 819457
[TBL] [Abstract][Full Text] [Related]
38. Presence in normal human urine of a hypotensive and platelet-activating phospholipid.
Sánchez-Crespo M; Iñarrea P; Alvarez V; Alonso F; Egido J; Hernando L
Am J Physiol; 1983 Jun; 244(6):F706-11. PubMed ID: 6859262
[TBL] [Abstract][Full Text] [Related]
39. Methods for determining the fraction of pulmonary surfactant lipid removed from the lung of beagle dogs by lavage.
Henderson F; Waide JJ; Pfleger RC
Arch Int Physiol Biochim; 1974; 82(2):259-72. PubMed ID: 4135858
[No Abstract] [Full Text] [Related]
40. The composition of pulmonary surfactant from diving mammals.
Miller NJ; Postle AD; Orgeig S; Koster G; Daniels CB
Respir Physiol Neurobiol; 2006 Jun; 152(2):152-68. PubMed ID: 16140043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
